Dr. Tanvir Bajwa Discusses the Effectiveness of the Evolut FX Transcatheter Aortic Valve System
By Rob Dillard, Dr. Tanvir Bajwa - Last Updated: May 19, 2023The next generation supra-annular, self-expanding Evolut FX TAVR system (Medtronic) has been designed to improve ease of use in coronary access through enhanced deliverability and trackability. Its improvements were assessed via a physician survey analysis, and the findings were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.
Advertisement
In this exclusive interview, DocWire News spoke with lead researcher Dr. Tanvir K. Bajwa about the FX system procedural outcomes following design enhancements.
Advertisement
Related Posts
Ticagrelor monotherapy is linked with similar rates of recurrent coronary revascularization compared with standard therapy.
Dr. George D. Dangas, about a study he led which analyzed the predictive value of the thrombotic risk criteria.
Pulmonary embolism patients treated with mechanical thrombectomy have improved outcomes and quality of life.
Marijuana users incur more than three times the risk of developing peripheral artery disease.
The novel Supira 10F system is a safe and effective percutaneous ventricular assist device for high-risk PCI.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.